VII. Assess long term efficacy (overall survival [OS]/disease free survival [DFS]) of FLAG consolidation or reinduction chemotherapy followed by "off-the-shelf" non HLA matched expanded cord blood cells in pediatric AML or acute leukemia of ambiguous lineage patients during long term follow up.